New Test for Rare Immunodeficiency
Researchers at the University of Basel have developed a test to quickly and reliably diagnose a rare and severe immune defect, hepatic veno-occlusive disease with immunodeficiency. They reported on their findings in the Journal of Clinical Immunology.
Rare diseases are often only diagnosed very late, especially since in many cases, diagnostic tests are not available or are only available in a few laboratories. Hepatic Veno-occlusive disease with immunodeficiency is a clear example of this. It is an immunodeficiency caused by a mutation in the gene Sp110, and children suffering from it often die of severe infections or liver failure during the first year of life.
First described in 1976, this disease is still difficult to treat and is often fatal. It is also unclear what function the Sp110 gene actually has and why Sp110 protein deficiency leads to a severe immune defect and liver disease.
Rapid detection of missing Sp110 protein
One reason for the lack of progress in the treatment of this disease is that it had previously not been possible to detect the expression of the Sp110 protein in immune cells without significant effort. Mike Recher’s research group from the University of Basel’s Department of Biomedicine has now published a new, quick and easy-to-use test that shows the presence of the Sp110 protein in immune cells from the patient’s blood.
The detection is based on flow cytometry, a method in which the properties of individual cells are measured using laser light. The researchers were able to use the test to reliably determine patients with different mutations in the Sp110 gene in a matter of hours.
“We expect that this test will soon be used in laboratories to diagnose a Sp110 deficiency,” says Professor Recher. “The test will also help us quickly discover more about the biological function of Sp110.”
This article has been republished from materials provided by the University of Basel. Note: material may have been edited for length and content. For further information, please contact the cited source.
Marquardsen, F. A., Baldin, F., Wunderer, F., Al-Herz, W., Mikhael, R., Lefranc, G., . . . Recher, M. (2017). Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency. Journal of Clinical Immunology. doi:10.1007/s10875-017-0431-5
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
New Blood Test Could Help Distinguish Heart Attack from Heart StrainNews
A new blood test developed by a UAlberta medical researcher is better at detecting damage to the heart caused by an actual heart attack. The test promises to improve how physicians diagnose and treat patients experiencing a possible heart attack.READ MORE
Comments | 0 ADD COMMENT
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018